Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 0.54 is 61% below its 5-year average of 1.38, near the low end of its 5-year range (0.11–4.36).
43.46% below its 12-month average of 0.96.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
0.54
PEG RATIO AVG TTM
0.96
PEG RATIO AVG 3Y
0.67
PEG RATIO AVG 5Y
1.38
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-43.46%
CURRENT VS 3Y AVG
-19.80%
CURRENT VS 5Y AVG
-60.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.87
median of 52 covered companies
CURRENT VS SECTOR MEDIAN
-71.12%
vs the sector median at left
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Doximity, Inc. (DOCS) | $4.63B | 0.54 | 0.96 | 0.67 | 1.38 |
| TransMedics Group, Inc. (TMDX)vs › | $3.19B | 0.05 | 0.05 | 1.65 | 1.32 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.65B | N/A | 0.84 | 0.69 | 0.69 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.19B | N/A | 0.12 | 0.27 | 0.46 |
| Oscar Health, Inc. (OSCR)vs › | $8.10B | 0.01 | 0.01 | 0.07 | 0.12 |
| Teladoc Health, Inc. (TDOC)vs › | $1.15B | N/A | 0.08 | 0.12 | 0.31 |
| NRC Health (NRC)vs › | $495.81M | N/A | 2.52 | 3.04 | 2.90 |
| Shoulder Innovations, Inc. (SI)vs › | $465.16M | N/A | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $9.93B | 0.27 | 0.23 | 2.94 | 3.14 |
| Henry Schein, Inc. (HSIC)vs › | $10.30B | 3.23 | 3.23 | 3.23 | 1.76 |
PEG Ratio
0.54
P/E Ratio
29.1
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-03-31 | 0.93 |
| 2024-03-31 | 0.98 |
| 2022-03-31 | 0.11 |
| 2021-03-31 | 4.36 |
| 2020-03-31 | 0.52 |
